Literature DB >> 12454947

D1 dopamine receptors in the mouse prefrontal cortex: Immunocytochemical and cognitive neuropharmacological analyses.

Michael S Lidow1, Phil-Ok Koh, Amy F T Arnsten.   

Abstract

Dopamine D1 receptors have critical neuromodulatory influences on the working memory functions of the prefrontal cortex, a brain region affected in many neuropsychiatric disorders. When D1 receptor agents are administered to rats or monkeys performing working memory tasks, an "inverted U" dose/response function is typically observed, whereby either too little or too much D1 receptor stimulation impairs working memory. There are two subtypes of D1 receptors, the D1A and the D1B (also known as the D1 and D5, respectively), but the relative contributions of these subtypes to prefrontal cortical function are not known, as there are no pharmacological agents that can distinguish between these receptors. Thus, genetically altered mice are needed to address this question. However, it is not known whether the mouse prefrontal cortex contains both D1A and D1B receptor subtypes, nor is it known whether mice will exhibit responses to D1 receptor agonists similar to those seen in rats and monkeys. The current study examined these issues by immunostaining the mouse brain with specific antibodies directed at the D1A and D1B receptor subtypes and by assessing the effects of increasing doses of a D1 receptor agonist, SKF81297, on spatial working memory performance in mice. Results indicate that mice are generally similar to monkeys and rats, expressing both D1A and D1B receptors in the prefrontal cortex and exhibiting an inverted "U" dose/response curve when administered SKF81297. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12454947     DOI: 10.1002/syn.10143

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  32 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex.

Authors:  Chiayu Q Chiu; Nagore Puente; Pedro Grandes; Pablo E Castillo
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Assessment of cognitive function in the heterozygous reeler mouse.

Authors:  Dilja D Krueger; Jessica L Howell; Britni F Hebert; Peter Olausson; Jane R Taylor; Angus C Nairn
Journal:  Psychopharmacology (Berl)       Date:  2006-09-15       Impact factor: 4.530

4.  Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth.

Authors:  Stéphane Budel; Thihan Padukkavidana; Betty P Liu; Zeny Feng; Fenghua Hu; Sam Johnson; Juha Lauren; James H Park; Aaron W McGee; Ji Liao; Althea Stillman; Ji-Eun Kim; Bao-Zhu Yang; Stefano Sodi; Joel Gelernter; Hongyu Zhao; Fuki Hisama; Amy F T Arnsten; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

5.  Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels.

Authors:  Nao J Gamo; Gyorgy Lur; Michael J Higley; Min Wang; Constantinos D Paspalas; Susheel Vijayraghavan; Yang Yang; Brian P Ramos; Kathy Peng; Anna Kata; Lindsay Boven; Faith Lin; Lisette Roman; Daeyeol Lee; Amy F T Arnsten
Journal:  Biol Psychiatry       Date:  2015-02-04       Impact factor: 13.382

Review 6.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

Review 7.  Biological and social influences on cognitive control processes dependent on prefrontal cortex.

Authors:  Adele Diamond
Journal:  Prog Brain Res       Date:  2011       Impact factor: 2.453

8.  Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.

Authors:  Rouba Kozak; Tamás Kiss; Keith Dlugolenski; David E Johnson; Roxanne R Gorczyca; Kyle Kuszpit; Brian D Harvey; Polina Stolyar; Stacey J Sukoff Rizzo; William E Hoffmann; Dmitri Volfson; Mihaly Hajós; Jennifer E Davoren; Amanda L Abbott; Graham V Williams; Stacy A Castner; David L Gray
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

9.  Cytoarchitectonic and chemoarchitectonic characterization of the prefrontal cortical areas in the mouse.

Authors:  H J J M Van De Werd; G Rajkowska; P Evers; Harry B M Uylings
Journal:  Brain Struct Funct       Date:  2010-03-12       Impact factor: 3.270

10.  Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats.

Authors:  Tracie A Paine; Rachael L Neve; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2009-04-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.